This website uses cookies

Read our Privacy policy and Terms of use for more information.

In partnership with

LUNCH BREAK READS

MONDAY, MAY 4, 2026

Happy Monday, Lunch Club!

I enjoyed every one of today’s stories for different reasons, and I hope one or all of these will scratch your itch today.

  • Scientists have spent decades underestimating bees. New lab experiments suggest they can count, teach each other tricks, and may even feel fear and joy.

  • An AP investigation found that adopted children make up an estimated 25 to 40 percent of kids in for-profit residential treatment centers, where private equity profits depend on keeping them there as long as possible.

  • A New York Times reporter spent the final days at a Pennsylvania dairy farm that has been in the same family since before the Civil War, ending with an auction attended by Amish families and cattle dealers.

  • A startup founder got FDA acknowledgment that her daily pill is likely to extend dogs' lives. Dogs, she argues, are just the first stop on the road to human longevity medicine.

Enjoy your lunch.

Brett

01 • ~20 Minute Read
National Geographic Hannah Nordhaus
Secrets of the bees: Revealing the sneaky genius of nature's brightest thinkers
Scientists once dismissed bee cognition as pure instinct. Decades of lab experiments have dismantled that assumption. Researcher Lars Chittka at Queen Mary University of London has shown bumblebees can count landmarks, pull strings for rewards, and teach those behaviors to colony mates. At UC Davis, biologist Felicity Muth found lone queen bumblebees learn faster than foraging workers. In Finland, Olli Loukola is testing whether bees can solve novel problems through insight rather than trial and error. The same intelligence that makes bees remarkable pollinators may also make them more adaptable to the parasites and habitat loss that have killed 55 percent of American colonies in the past year.
E-mail Required →
02 • ~15 Minute Read
Associated Press Claire Galofaro and Sally Ho
Adopted and Locked Away: Kids promised ‘forever homes’ instead confined in for-profit institutions
An AP investigation finds adopted children make up an estimated 25 to 40 percent of kids in residential treatment centers despite being just 2 percent of the American child population. Charging up to $20,000 a month, many facilities market treatment for reactive attachment disorder, a diagnosis experts say is routinely misapplied and clinically unsupported for the teenagers confined there. Children report physical restraint, strip searches, and punishments including forced labor. At least two facilities run by one company, Family Help and Wellness, closed after children died. Private equity firms have moved into the sector, with analysts noting 20 percent profit margins tied to long enrollment stays and minimal staffing costs.
Read the Story →
03 • ~15 Minute Read
The New York Times Magazine Eli Saslow
The Last Days of Butter Ridge
Brad Watson, 41, milked his last cows on a 326-acre Pennsylvania farm that four generations of his family had worked since before the Civil War. Feed and fuel costs rose up to 500 percent while milk prices stagnated. New tariffs cut into export markets, and conflict near the Strait of Hormuz sent fertilizer prices up 70 percent. Farm bankruptcies rose 55 percent in 2024, 46 percent in 2025, and another 70 percent so far in 2026. Brad had voted for Trump expecting relief. None came. The auction drew Amish families, cattle dealers, and beef buyers. When it ended, Brad walked back into the empty barn and found his 14-year-old son Boyd, leading the one calf they had kept.
Unlocked for LBR Readers →
04 • ~15 Minute Read
The Atlantic Michael Crawley
Your Next Dog May Live Longer
Celine Halioua founded Loyal in 2019 with a plan to extend dogs' lives using a daily pill that restores insulin sensitivity, a mechanism tied to aging across multiple organ systems. In February 2025, the FDA deemed the drug reasonably likely to be effective, an unusual approval path for a life-extension rather than disease-specific compound. Loyal has enrolled more than 1,300 dogs in a five-year clinical trial. The pill could sell for around $100 a month. Halioua's longer goal is human longevity, using dog trials as a faster regulatory pathway. Dogs, she notes, have always gone first into dangerous new frontiers on behalf of their owners.
Unlocked for LBR Readers →

Support the Club

This newsletter is free. If you read it regularly and want to help keep it that way, a small contribution means a lot.

SUPPORT LBR →

Keep Reading